Atıf Formatları
Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Mitranovici Et Al. , "Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review," PHARMACEUTICALS , vol.17, no.3, pp.1-20, 2024

Mitranovici, M. Et Al. 2024. Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review. PHARMACEUTICALS , vol.17, no.3 , 1-20.

Mitranovici, M., Chiorean, D. M., Moraru, L., Moraru, R., Caravia, L., Tiron, A. T., ... Cotoi, T. C.(2024). Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review. PHARMACEUTICALS , vol.17, no.3, 1-20.

Mitranovici, Melinda-Ildiko Et Al. "Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review," PHARMACEUTICALS , vol.17, no.3, 1-20, 2024

Mitranovici, Melinda-Ildiko Et Al. "Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review." PHARMACEUTICALS , vol.17, no.3, pp.1-20, 2024

Mitranovici, M. Et Al. (2024) . "Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review." PHARMACEUTICALS , vol.17, no.3, pp.1-20.

@article{article, author={Melinda-Ildiko Mitranovici Et Al. }, title={Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review}, journal={PHARMACEUTICALS}, year=2024, pages={1-20} }